Navigation Links
Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
Date:4/15/2008

Clinical studies show Treximet provided significantly more patients

migraine pain relief compared to sumatriptan 85 mg

LONDON, April 15 /PRNewswire-FirstCall/ -- GlaxoSmithKline (LSE: GSK) (NYSE: GSK) and POZEN Inc. (Nasdaq: POZN) announced today that the FDA has approved Treximet for the acute treatment of migraine attacks with or without aura in adults. Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines pioneered by GSK, and an anti-inflammatory pain reliever in a single tablet.

Treximet contains 85 mg sumatriptan, formulated with RT Technology(TM), and 500 mg naproxen sodium. Sumatriptan is the active ingredient in Imitrex(R) Tablets, available in 25 mg, 50 mg and 100 mg strengths. In clinical trials, Treximet provided a significantly greater percentage of patients migraine pain relief at two hours compared to sumatriptan 85 mg or naproxen sodium 500 mg alone. In addition, Treximet provided more patients sustained migraine pain relief from two to 24 hours compared to the individual components.

"Migraine patients want their medicine to work early, and to continue to provide relief," said Dr. Stephen Silberstein, professor of neurology and director of the Jefferson Headache Center at Thomas Jefferson University and an investigator who participated in clinical trials. "The FDA approval of Treximet is good news for migraine patients because clinical trials showed that Trexime
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium
2. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
3. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
4. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
5. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
7. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
10. Newly Approved HIV Drug Shows Great Promise
11. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015 Report Details ... Market, its R&D and Sales Potentials ... cancer-treating medicines? Visiongain,s new report gives you revenue predictions for ... discover financial data, R&D trends, opportunities, interviews and revenue forecasts. ... you see forecasted sales to 2025 at overall world market, ...
(Date:9/3/2015)... Sept. 3,  2015 About artificial ... devices, which are implanted or integrated into ... These include artificial heart, kidney, pancreas, and ... (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, ... organs. These organs are incorporated with different ...
(Date:9/3/2015)... , Sept. 3, 2015 Nevro Corp. ... that is providing innovative evidence-based solutions for the treatment ... be presenting at the Morgan Stanley Global Healthcare Conference ... Nevro management is scheduled to present ... via a live audio webcast, accessible in the "Investors" ...
Breaking Medicine Technology:World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Artificial Organ Market 2015-2019 2
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one of the ... fertility "ManchVegas Happy Hour" in Manchester for women who wish to learn more about ... on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM ...
(Date:9/4/2015)... Texas (PRWEB) , ... September 04, 2015 , ... ... recipient of three separate “Partner of the Year” awards at this year’s Microsoft ... being named Microsoft’s 2015 “Partner of the Year” Award Winner for Data Platform ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Many consumers are looking for a quick ... be their solution. , The patent-pending K Med Cups provide a quick and simple way ... to relieve a cold, flu or cough. As a result, they enhance comfort and health. ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... and development of its first neighborhood created specifically for adults with intellectual, developmental ... the Phoenix Metro area and feature 30 cottage or “pocket” homes. In this ...
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, the online ... that cannot be passed up. FiltersFast.com, will ship all orders over $50.00 ... filtration product replacements. Take advantage of this promotion now through September 8, 2015. ...
Breaking Medicine News(10 mins):Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2
... Accelerated growth of tumors seen in mouse study , , ... in the inorganic phosphates found in many natural and ... rats, South Korean researchers report. , "Our study suggests ... for lung cancer treatment as well as prevention," Myung-Haing ...
... among those whose families don,t accept them , , MONDAY, ... families rejected them when they were younger are more ... use and suicide attempts, new research suggests. , The ... a child,s sexuality directly causes problems later in life. ...
... high-fat diet can not only lead to overweight because ... balance of circadian rhythms everyone,s 24-hour biological clock, ... The biological clock regulates the expression and/or activity of ... the clock can lead to such phenomena as hormone ...
... Second Harvest Heartland, the,Upper Midwest,s largest hunger relief ... General Mills and NBC,s "The Biggest Loser.",Through the ... dieters,in Minnesota and western Wisconsin pledge to lose ... cents to Second Harvest Heartland -- enough to ...
... bean plant Ricinus communis is considered one of the ... tissue damage and inflammation and can result in death. ... of castor beans whereby the toxin is released after ... severe gastrointestinal damage with symptoms and death due to ...
... for the relief of fever, headaches, and other minor ... are well documented and acetaminophen is accepted to be ... of short-term, especially high-dose NSAID and acetaminophen use have ... be published on November 21 , 2008 in the ...
Cached Medicine News:Health News:Food Phosphates Might Spur Lung Cancer 2Health News:Food Phosphates Might Spur Lung Cancer 3Health News:Rejection of Gay Teens Linked to Later Troubles 2Health News:Rejection of Gay Teens Linked to Later Troubles 3Health News:Another reason to avoid high-fat diet -- it can disrupt our biological clock 2Health News:Second Harvest Heartland, Feeding America, General Mills, and 'The Biggest Loser' Team to Help Community Lose Weight and Raise Funds to Feed the Hungry 2Health News:Second Harvest Heartland, Feeding America, General Mills, and 'The Biggest Loser' Team to Help Community Lose Weight and Raise Funds to Feed the Hungry 3Health News:Second Harvest Heartland, Feeding America, General Mills, and 'The Biggest Loser' Team to Help Community Lose Weight and Raise Funds to Feed the Hungry 4Health News:Acute gastric injury due to high-dose analgesics? 2
... The DASCOR Disc Arthroplasty System consists ... expandable polyurethane balloon which is inserted into ... been removed. The balloon is then injected ... complete, patient specific implant that conforms to ...
... Bio-Rad's CODA® Automated EIA Analyzer ... a wide range of complex microplate-based ... flexibility and efficiency to busy laboratories. ... automatically optimizes the processing of assays ...
... the performance of the ADVIA Centaur Immunoassay ... in a benchtop model with a footprint of ... the ADVIA Centaur CP fits in anywhere. More ... lab with optimal productivity, speed and efficiency while ...
... available techniques for prenatal diagnosis (CVS and ... use a small but significant chance of ... care offers invasive prenatal baby gender testing ... chromosomal or genetic abnormalities are greater than ...
Medicine Products: